Arcutis Biotherapeutics (ARQT) Change in Cash (2019 - 2026)
Arcutis Biotherapeutics (ARQT) posted quarterly Change in Cash of -$8.1 million for Q1 2026, up 55.32% year-over-year from -$5.2 million in Q1 2025, and down 93.33% quarter-over-quarter from -$4.2 million in Q4 2025.
Arcutis Biotherapeutics (ARQT) Change in Cash (2019 - 2026) Analysis & Trends
Arcutis Biotherapeutics' Change in Cash history runs 8 years deep, the most recent figure standing at -$8.1 million for Q1 2026.
- In Q1 2026, Change in Cash rose 55.32% year-over-year to -$8.1 million; the TTM figure through Mar 2026 stood at -$18.7 million (up 86.39% YoY), while the FY2025 annual figure was -$28.7 million, down 65.43% from the prior year.
- Change in Cash for Q1 2026 stood at -$8.1 million, down from -$4.2 million in the prior quarter.
- The five-year high for Change in Cash was $101.4 million in Q1 2024, with the low at -$105.8 million in Q2 2024.
- The 5-year median for Change in Cash is -$8.1 million (2026), against an average of -$3.7 million.
- Peak annual rise in Change in Cash reached 2045.99% in 2024, while the deepest fall reached 546.36% in 2024.
- Arcutis Biotherapeutics' Change in Cash stood at -$27.9 million in 2022, then surged by 31.64% to -$19.1 million in 2023, then slumped by 233.02% to -$63.5 million in 2024, then soared by 93.37% to -$4.2 million in 2025, then plunged by 93.33% to -$8.1 million in 2026.
- Business Quant data shows ARQT's Change in Cash at -$8.1 million in Q1 2026, -$4.2 million in Q4 2025, and -$25.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 427.25 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.97 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.94 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.42 Mn |
| 10 | Arcutis Biotherapeutics | 3.29 Bn | 3.05 Bn | 118.92 Mn | -641,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -641,000.00 |
| Mar 31, 2026 | -8.15 Mn |
| Dec 31, 2025 | -4.21 Mn |
| Sep 30, 2025 | -25.62 Mn |
| Jun 30, 2025 | 19.33 Mn |
| Mar 31, 2025 | -18.23 Mn |
| Dec 31, 2024 | -63.52 Mn |
| Sep 30, 2024 | 50.58 Mn |
| Jun 30, 2024 | -105.83 Mn |
| Mar 31, 2024 | 101.39 Mn |
| Dec 31, 2023 | -19.07 Mn |
| Sep 30, 2023 | 2.36 Mn |
| Jun 30, 2023 | 23.71 Mn |
| Mar 31, 2023 | 27.46 Mn |
| Dec 31, 2022 | -27.90 Mn |
| Sep 30, 2022 | 20.03 Mn |
| Jun 30, 2022 | -8.28 Mn |
| Mar 31, 2022 | -26.96 Mn |
| Dec 31, 2021 | 44.67 Mn |
| Sep 30, 2021 | -37.35 Mn |